Atlas Private Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Atlas Private Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-110	Closed	-$2K	–	935
2021 Q1	$2K	Hold	110	–	–	﹤0.01%	757
2020 Q4	$2K	Hold	110	–	–	﹤0.01%	664
2020 Q3	$2K	Hold	110	–	–	﹤0.01%	595
2020 Q2	$2K	Buy	+110	New	+$1.98K	﹤0.01%	610

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Atlas Private Wealth Advisors's TAK Position: Q2 2021 in Review

Atlas Private Wealth Advisors sold out of Takeda Pharmaceutical (TAK) in Q2 2021, closing a stake of 110 shares — an estimated $2K sold.

Atlas Private Wealth Advisors first reported a position in TAK in Q2 2020 and held it in 4 quarters. The position peaked at $2K in Q1 2021. 304 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

Atlas Private Wealth Advisors reported no remaining Takeda Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 110 Takeda Pharmaceutical shares in Q2 2021, an estimated $2K.
Atlas Private Wealth Advisors first reported a position in Takeda Pharmaceutical in Q2 2020 and held it in 4 quarters.
Atlas Private Wealth Advisors's Takeda Pharmaceutical position peaked at $2K in Q1 2021.
304 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.